ATHERO-FLUX
Targeting novel lipid
pathways for treatment
of cardiovascular disease
Participants
Number and logo
Participant short and full name
(click for website)
City and Country
Principal investigator
(click for e-mail)
1
UOXF
The Chancellor, Masters and Scholars of the University of Oxford
Oxford
United Kingdom
Marc Feldmann
2
Zora
Zora Biosciences Ltd
Espoo
Finland
Reijo Laaksonen
3
CENIX
Cenix Biosciences Ltd
TERMINATED February 28th, 2015
Dresden
Germany
Birte Sönnichsen
4
Roche
Roche Innovation Center Copenhagen A/S
Copenhagen
Denmark
Marie Wickström Lindholm
5
BRFAA
Biomedical Research Foundation Academy of Athens
Athens
Greece
Evangelos Andreakos
6
TAUH
Pikkanmaa Hospital District
Tampere
Finland
Katriina Aalto-Setälä
7
IP
Institut Pasteur
Paris
France
Philippe J. Sansonetti
8
KI
Karolinska Institutet
Stockholm
Sweden
Göran K. Hansson
9
SDU
Syddansk Universitet
Odense M
Denmark
Ole N. Jensen
10
WEIZMANN
Weizmann Institute of Science
Rehovot
Israel
Tony Futerman
11
ALTA
ALTA Ricerca e Sviluppo
in Biotecnologie S.r.l.u.
Siena
Italy
Paola Cesaroni
11
SITOOLS BIOTECH GMBH
siTOOLs Biotech GmbH
(from March 1st, 2015)
Planegg
Germany
Michael Hannus
Home
Project info
Structure
Objectives
Participants
Press release
Publications
Meetings
Training activities
Reserved area